Study Shows Zika Virus Persists in Body Fluids
By LabMedica International staff writers Posted on 18 Oct 2018 |

Image: The GenoAmp Trioplex Real-Time RT-PCR Zika/Den/Chiku kit is a real-time molecular diagnostic test for the screening and differentiation of Zika, dengue and chikungunya virus, extracted from human plasma/serum (Photo courtesy of Mediven).
Although most Zika virus (ZIKV) infections are transmitted by infected mosquitoes, ZIKV transmission has been documented as occurring through sexual contact, blood transfusion, laboratory exposure, and both intrauterine and intrapartum transmission.
ZIKV infection can be diagnosed through detection of ZIKV RNA in blood, urine, and other body fluids by reverse-transcriptase–polymerase-chain-reaction (RT-PCR) assays. However, the frequency with which ZIKV RNA can be detected in various body fluids and the length of time that it remains detectable are not well understood.
An international team of scientists cooperating with the Centers for Disease Control and Prevention (CDC, Atlanta, GA, USA) evaluated samples obtained from 295 participants (including 94 men who provided semen specimens) in whom ZIKV RNA was detected on RT-PCR assay in urine or blood at an enhanced arboviral clinical surveillance site. The study was based on 295 people in Puerto Rico infected with Zika beginning in May 2016. The team collected samples of serum, urine, saliva, semen, and vaginal secretions weekly for the first month and at 2, 4, and 6 months after diagnosis. The mean age of the participants was 36 years; 51% were female, including nine who were pregnant.
Specimens, measuring 200 μL, were tested by means of the Trioplex RT-PCR assay, as recommended by the CDC for the detection of dengue, chikungunya, and ZIKV RNA. In addition, they performed validation analyses for the use of the Trioplex RT-PCR assay in semen. Serum was tested by means of anti–ZIKV IgM antibody capture enzyme-linked immunosorbent assay. ZIKV isolation was attempted through culture in a subset of semen and serum specimens.
The investigators reported that the median and 95th percentile for the time until the loss of Zika RNA detection were 15 days, and 41 days respectively, in serum; 11 days, and 34 days in urine; and 42 days and 120 days in semen. Less than 5% of participants had detectable Zika RNA in saliva or vaginal secretions. Compared with preliminary findings, the median time of RNA clearance in semen rose from 34 to 42 days, and for 95th percentile it climbed from 81 to 120 days.
The authors concluded that the prolonged time until ZIKV RNA clearance in serum in this study may have implications for the diagnosis and prevention of ZIKV infection. In 95% of the men in this study, ZIKV RNA was cleared from semen after approximately four months.
Gabriela Paz-Bailey, MD, PhD, the lead author of the study, said, “Anyone concerned about getting or passing Zika through sex should use condoms every time they have sex or not have sex for at least three months after symptom onset to allow Zika virus to clear from semen. Because Zika infection during pregnancy can cause severe birth defects, pregnant women should not travel to areas with Zika transmission risk. All travelers should strictly follow steps to prevent mosquito bites and prevent sexual transmission during and after the trip.” The study was published on September 27, 2018, in The New England Journal of Medicine.
Related Links:
Centers for Disease Control and Prevention
ZIKV infection can be diagnosed through detection of ZIKV RNA in blood, urine, and other body fluids by reverse-transcriptase–polymerase-chain-reaction (RT-PCR) assays. However, the frequency with which ZIKV RNA can be detected in various body fluids and the length of time that it remains detectable are not well understood.
An international team of scientists cooperating with the Centers for Disease Control and Prevention (CDC, Atlanta, GA, USA) evaluated samples obtained from 295 participants (including 94 men who provided semen specimens) in whom ZIKV RNA was detected on RT-PCR assay in urine or blood at an enhanced arboviral clinical surveillance site. The study was based on 295 people in Puerto Rico infected with Zika beginning in May 2016. The team collected samples of serum, urine, saliva, semen, and vaginal secretions weekly for the first month and at 2, 4, and 6 months after diagnosis. The mean age of the participants was 36 years; 51% were female, including nine who were pregnant.
Specimens, measuring 200 μL, were tested by means of the Trioplex RT-PCR assay, as recommended by the CDC for the detection of dengue, chikungunya, and ZIKV RNA. In addition, they performed validation analyses for the use of the Trioplex RT-PCR assay in semen. Serum was tested by means of anti–ZIKV IgM antibody capture enzyme-linked immunosorbent assay. ZIKV isolation was attempted through culture in a subset of semen and serum specimens.
The investigators reported that the median and 95th percentile for the time until the loss of Zika RNA detection were 15 days, and 41 days respectively, in serum; 11 days, and 34 days in urine; and 42 days and 120 days in semen. Less than 5% of participants had detectable Zika RNA in saliva or vaginal secretions. Compared with preliminary findings, the median time of RNA clearance in semen rose from 34 to 42 days, and for 95th percentile it climbed from 81 to 120 days.
The authors concluded that the prolonged time until ZIKV RNA clearance in serum in this study may have implications for the diagnosis and prevention of ZIKV infection. In 95% of the men in this study, ZIKV RNA was cleared from semen after approximately four months.
Gabriela Paz-Bailey, MD, PhD, the lead author of the study, said, “Anyone concerned about getting or passing Zika through sex should use condoms every time they have sex or not have sex for at least three months after symptom onset to allow Zika virus to clear from semen. Because Zika infection during pregnancy can cause severe birth defects, pregnant women should not travel to areas with Zika transmission risk. All travelers should strictly follow steps to prevent mosquito bites and prevent sexual transmission during and after the trip.” The study was published on September 27, 2018, in The New England Journal of Medicine.
Related Links:
Centers for Disease Control and Prevention
Latest Microbiology News
- Handheld Device Delivers Low-Cost TB Results in Less Than One Hour
- New AI-Based Method Improves Diagnosis of Drug-Resistant Infections
- Breakthrough Diagnostic Technology Identifies Bacterial Infections with Almost 100% Accuracy within Three Hours
- Innovative ID/AST System to Help Diagnose Infectious Diseases and Combat AMR
- Gastrointestinal Panel Delivers Rapid Detection of Five Common Bacterial Pathogens for Outpatient Use
- Rapid PCR Testing in ICU Improves Antibiotic Stewardship
- Unique Genetic Signature Predicts Drug Resistance in Bacteria
- Unique Barcoding System Tracks Pneumonia-Causing Bacteria as They Infect Blood Stream
- Rapid Sepsis Diagnostic Test Demonstrates Improved Patient Care and Cost Savings in Hospital Application
- Rapid Diagnostic System to Detect Neonatal Sepsis Within Hours
- Novel Test to Diagnose Bacterial Pneumonia Directly from Whole Blood
- Interferon-γ Release Assay Effective in Patients with COPD Complicated with Pulmonary Tuberculosis
- New Point of Care Tests to Help Reduce Overuse of Antibiotics
- 30-Minute Sepsis Test Differentiates Bacterial Infections, Viral Infections, and Noninfectious Disease
- CRISPR-TB Blood Test to Enable Early Disease Diagnosis and Public Screening
- Syndromic Panel Provides Fast Answers for Outpatient Diagnosis of Gastrointestinal Conditions
Channels
Clinical Chemistry
view channel
‘Brilliantly Luminous’ Nanoscale Chemical Tool to Improve Disease Detection
Thousands of commercially available glowing molecules known as fluorophores are commonly used in medical imaging, disease detection, biomarker tagging, and chemical analysis. They are also integral in... Read more
Low-Cost Portable Screening Test to Transform Kidney Disease Detection
Millions of individuals suffer from kidney disease, which often remains undiagnosed until it has reached a critical stage. This silent epidemic not only diminishes the quality of life for those affected... Read more
New Method Uses Pulsed Infrared Light to Find Cancer's 'Fingerprints' In Blood Plasma
Cancer diagnoses have traditionally relied on invasive or time-consuming procedures like tissue biopsies. Now, new research published in ACS Central Science introduces a method that utilizes pulsed infrared... Read moreMolecular Diagnostics
view channel
Simple Blood Test Improves Heart Attack and Stroke Risk Prediction
Troponin is a protein found in heart muscle cells that is released into the bloodstream when the heart is damaged. High-sensitivity troponin blood tests are commonly used in hospitals to diagnose heart... Read more
Blood Biomarker Test Could Detect Genetic Predisposition to Alzheimer’s
New medications for Alzheimer’s disease, the most common form of dementia, are now becoming available. These treatments, known as “amyloid antibodies,” work by promoting the removal of small deposits from... Read more
Novel Autoantibody Against DAGLA Discovered in Cerebellitis
Autoimmune cerebellar ataxias are strongly disabling disorders characterized by an impaired ability to coordinate muscle movement. Cerebellar autoantibodies serve as useful biomarkers to support rapid... Read more
Gene-Based Blood Test Accurately Predicts Tumor Recurrence of Advanced Skin Cancer
Melanoma, an aggressive form of skin cancer, becomes extremely difficult to treat once it spreads to other parts of the body. For patients with metastatic melanoma tumors that cannot be surgically removed... Read moreHematology
view channel
New Scoring System Predicts Risk of Developing Cancer from Common Blood Disorder
Clonal cytopenia of undetermined significance (CCUS) is a blood disorder commonly found in older adults, characterized by mutations in blood cells and a low blood count, but without any obvious cause or... Read more
Non-Invasive Prenatal Test for Fetal RhD Status Demonstrates 100% Accuracy
In the United States, approximately 15% of pregnant individuals are RhD-negative. However, in about 40% of these cases, the fetus is also RhD-negative, making the administration of RhoGAM unnecessary.... Read moreImmunology
view channel
Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer
Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more
Machine Learning-Enabled Blood Test Predicts Immunotherapy Response in Lymphoma Patients
Chimeric antigen receptor (CAR) T-cell therapy has emerged as one of the most promising recent developments in the treatment of blood cancers. However, over half of non-Hodgkin lymphoma (NHL) patients... Read morePathology
view channel
Spit Test More Accurate at Identifying Future Prostate Cancer Risk
Currently, blood tests that measure the level of a protein called prostate-specific antigen (PSA) are commonly used to identify men at higher risk for prostate cancer. This test is typically used based... Read more
DNA Nanotechnology Boosts Sensitivity of Test Strips
Since the Covid-19 pandemic, most people have become familiar with paper-based rapid test strips, also known as lateral flow immunoassays (LFIAs). These tests are used to quickly detect biomarkers that... Read more
Novel UV and Machine Learning-Aided Method Detects Microbial Contamination in Cell Cultures
Cell therapy holds great potential in treating diseases such as cancers, inflammatory conditions, and chronic degenerative disorders by manipulating or replacing cells to restore function or combat disease.... Read moreTechnology
view channel
Disposable Microchip Technology Could Selectively Detect HIV in Whole Blood Samples
As of the end of 2023, approximately 40 million people globally were living with HIV, and around 630,000 individuals died from AIDS-related illnesses that same year. Despite a substantial decline in deaths... Read more
Pain-On-A-Chip Microfluidic Device Determines Types of Chronic Pain from Blood Samples
Chronic pain is a widespread condition that remains difficult to manage, and existing clinical methods for its treatment rely largely on self-reporting, which can be subjective and especially problematic... Read more
Innovative, Label-Free Ratiometric Fluorosensor Enables More Sensitive Viral RNA Detection
Viruses present a major global health risk, as demonstrated by recent pandemics, making early detection and identification essential for preventing new outbreaks. While traditional detection methods are... Read moreIndustry
view channel
Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions
Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Grifols and Tecan’s IBL Collaborate on Advanced Biomarker Panels
Grifols (Barcelona, Spain), one of the world’s leading producers of plasma-derived medicines and innovative diagnostic solutions, is expanding its offer in clinical diagnostics through a strategic partnership... Read more